David J. McConkey, PhD of Johns Hopkins Greensberg Bladder Cancer Institute discusses genomics and how they change treatment for bladder cancer subtypes at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.
Advertisement
Advertisement